API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. KQ /
  3. 048410.KQ

Hyundai Bioscience Co. Ltd (048410 KQ) stock market data APIs

₩14050 50(0.4%) as of November 22, 2024
Price chart is built with Anychart

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.

Hyundai Bioscience Co. Ltd Financial Data Overview

14000
14050
-
14230
13800
13200-30950
574 196 M
39 819 K
9 240 M
-128.7747
1.033
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '048410',
Type: 'Common Stock',
Name: 'Hyundai Bioscience Co. Ltd',
Exchange: 'KQ',
CurrencyCode: 'KRW',
CurrencyName: 'Korean Won',
CurrencySymbol: '₩',
CountryName: 'Korea',
CountryISO: 'KR',
OpenFigi: 'BBG000NH45P3',
ISIN: 'KR7048410005',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Hyundai Bioscience Co. Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 9 240 M
  • EBITDA -7 293 945 344
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Hyundai Bioscience Co. Ltd Earnings via APIs

  • Latest Release 2024-11-12
  • EPS/Forecast NaN

Get Hyundai Bioscience Co. Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Hyundai Bioscience Co. Ltd latest news via APIs

Hyundai Bioscience announces that "Xafty is the only antiviral that can be immediately used for the treatment of Dengue fever"

Hyundai Bioscience presented data at IDWeek™ 2023 that Dengue fever, which has no cure despite the rapid increase in deaths, can be treated with Xafty Hyundai Bioscience offered also to provide Xa...

The 'Penicillin' of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug

- Professor Heungjeong Woo of Hallym University College of Medicine, announced the result of Xafty's clinical study at Emerging Science Session of the American Society for Microbiology (ASM) Microbe 2...
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com